Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells - Test2 - elhamkhani - TriplyDB

Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells

Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells

http://www.wikidata.org/entity/Q27026350

about

Mesenchymal Stem Cells after Polytrauma: Actor and Target Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization Cell-based therapy for traumatic brain injury Therapeutic use of stem cells for cardiovascular disease Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence Extracellular vesicle-mediated delivery of molecular compounds into gametes and embryos: learning from nature Sepsis: in search of cure.Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications Melatonin Protects Human Adipose-Derived Stem Cells from Oxidative Stress and Cell Death Pretreatment with Lycopene Attenuates Oxidative Stress-Induced Apoptosis in Human Mesenchymal Stem Cells.MicroRNAs Involved in Asthma After Mesenchymal Stem Cells Treatment.Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioid-induced Hyperalgesia.Hypoxia-induced expression of cellular prion protein improves the therapeutic potential of mesenchymal stem cells Purification and differentiation of human adipose-derived stem cells by membrane filtration and membrane migration methods.Clinical Trials With Mesenchymal Stem Cells: An Update.Immunomodulatory effect of mesenchymal stem cells on the immune response of macrophages stimulated by Aspergillus fumigatus conidia.Concise Review: Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction Following Trauma or Sepsis.Postinjury Inflammation and Organ Dysfunction.Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence.Endothelial Progenitor Cells Correlated with Oxidative Stress after Mild Traumatic Brain Injury.Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery.The Contribution of Adipose Tissue-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma to the Treatment of Chronic Equine Laminitis: A Proof of Concept.Mesenchymal stem cells decrease lung inflammation during sepsis, acting through inhibition of the MAPK pathway.Mesenchymal stem cells: A double-edged sword in radiation-induced lung injury.Protective Effects of Neural Crest-Derived Stem Cell-Conditioned Media against Ischemia-Reperfusion-Induced Lung Injury in Rats.Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression.Treating childhood traumatic brain injury with autologous stem cell therapy.Delivery of Mesenchymal Stem Cells from Gelatin-Alginate Hydrogels to Stomach Lumen for Treatment of Gastroparesis.Biomarkers for Early Acute Kidney Injury Diagnosis and Severity Prediction: A Pilot Multicenter Canadian Study of Children Admitted to the ICU.CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.Bone marrow‑derived mesenchymal stem cell‑conditioned medium attenuates tubulointerstitial fibrosis by inhibiting monocyte mobilization in an irreversible model of unilateral ureteral obstruction.Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models.Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase.Genetic Modification of Mesenchymal Stem Cells Overexpressing Angiotensin II Type 2 Receptor Increases Cell Migration to Injured Lung in LPS-Induced Acute Lung Injury Mice Pioglitazone Protects Mesenchymal Stem Cells against -Cresol-Induced Mitochondrial Dysfunction via Up-Regulation of PINK-1

P2860

Q26747314-252117EF-4861-449D-838B-D92DED82C592 Q26770107-6A7E2B95-8E8E-402D-9DF7-261B2FB2043B Q26800098-6ECFA3E4-EE49-4A0A-8359-E44043295ACD Q26998959-AB7AD8D1-BA55-4549-9B14-5831DCC520AA Q28076187-4CE15BD0-B894-4DAF-BE60-BE4329665DC3 Q28079089-C7F1E085-942D-4B6B-B70D-466FBD00D620 Q28083833-0A2B53CC-8D5E-442C-AF96-6DD4E5F702B4 Q30251753-17BF2378-41D1-470E-AEE5-62196670E74D Q33615105-03EC15D5-DDA1-45A3-9240-D3161445D772 Q33851544-CAF53329-27A7-43D3-9C1A-0FF6DB05503E Q36027693-483B6585-3495-49E1-8969-F073512EFAF9 Q36218371-070FD260-097A-4AAB-9188-7857ECAF12C1 Q37054490-472385C0-B6D6-40A5-BBAE-9B8F03F3C51E Q37198850-055E07F1-B797-4095-B678-F7D4A92F61E1 Q37465883-432AA1E0-C425-44F6-9007-9784A9296FCC Q37576020-7A594DD5-93B7-4732-AAE1-2BAACF7512AA Q38596084-009BE3A6-2374-4B15-A481-E4DE81BB27F4 Q38803607-CFB452A7-27DF-4830-8BD3-C516B4A7F83C Q39020468-A43AC620-E912-4959-853D-2DE2D2BE57E1 Q39022520-B712643E-8ACD-4E12-8044-0C8A9902CBA9 Q41205103-686F629B-AAB4-4222-B0A1-34EF591679BD Q41352181-E4BB36AC-3374-403C-9977-71E22AAEA9F6 Q46689376-B9AA9932-888F-456F-9F9C-438935ED3133 Q47158525-04DC27F2-2BC6-41BA-B0E3-B1670B64CFA3 Q47260064-6AF7B479-E57E-4F4B-BC0A-301028D73E03 Q47566394-1EE574CB-F2D1-4034-A66C-0D481C83F336 Q47878925-6C4433C7-36B5-41FE-B92D-262FF55576AE Q47991605-F0263C77-7E07-413C-9D12-2DF0AD05853C Q50109544-6F20F069-DDF7-4951-9065-C4258BEEE19F Q50133827-22A15234-12B0-4B16-9F40-EC479BCA6341 Q51042065-9D0AE2DF-6B84-4063-81D7-CA992ACF5277 Q53076778-A8FE9A72-B0E3-4141-9481-90B7E090C74C Q54092894-0EF1C43D-557D-427A-B0AD-890C1B61163B Q55401793-CCCCFA70-CEBF-4542-AEB3-81B299073DAA Q55508260-0E2130B8-36A0-4044-A0B7-5FACABA1B954 Q58724866-179253A3-203D-4CD1-B450-A87CE4C0F8D1 Q59133993-BF725011-1FA4-4D7D-9D33-E0F9C5EA4408

P2860

Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells

http://www.wikidata.org/entity/Q27026350

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@ast

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@en

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@nl

type

label

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@ast

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@en

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@nl

prefLabel

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@ast

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@en

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@nl

P1433

Q27026350-7A2B32DC-E3BA-461E-9FA5-BCBDBA31F6D5

P1476

Q27026350-3F6DA9E4-A276-40AB-917C-DCD5AEB1D1EA

P2093

Q27026350-5DB86A84-6755-4F2C-9754-FB170431B366

Q27026350-86551546-2CC8-4592-B1F4-2D127DF0EDAF

Q27026350-90342EC5-8072-40B5-932E-2AC9F763B1D9

Q27026350-BE1BAE39-20DD-41BF-8500-2A7426FF6046

Q27026350-F74234D1-FE9A-429C-B5E4-91E0B2FC8F3E

P2860

Q27026350-0070959B-637D-4FCA-BE7B-FD59A816C4F2

Q27026350-015B2BCB-2493-42B1-B21C-0CACB9A1C5BB

Q27026350-01DB4698-7C0F-41F7-A0EE-C1A324906010

Q27026350-026EC85C-D5D3-4FAF-8604-5C2904AE593B

Q27026350-03872B67-287F-4713-A47D-DBE005A78F4C

Q27026350-0395A9EE-BE73-496F-BFC4-19380D781CC3

Q27026350-03C6B331-D484-45B8-821D-19D193DC4EA5

Q27026350-046AB32C-77A9-4814-BA6D-C3CF4759DDC7

Q27026350-060F15FB-4709-42A4-9102-6E6F93049CD7

Q27026350-06591A9F-2E80-4B02-9B12-85561C953F0B

P304

Q27026350-9797A79A-16E1-48E4-BB4F-82D8794E8607

P31

Q27026350-A1EABC73-F7F0-4D62-B1E4-3E954CB65B3E

Q27026350-a5c25664-56f3-4fb3-b904-7849d9916b24

P3181

Q27026350-7D7A2A4C-24E5-455F-82B3-36A059028800

P356

Q27026350-3898B965-36EA-45DD-9816-5C6B5D45D278

P407

Q27026350-595FF52A-BD09-4C87-B6B1-A0BAC3CA4027

P433

Q27026350-60DCB74A-8B26-43FD-8D48-88D98A02B28F

P478

Q27026350-E55697C1-7A45-4BD4-945A-823BA4CF2486

P50

Q27026350-AF50EAE9-FDD4-4C2C-9F5B-0DC8247512D4

P577

Q27026350-3A7C170D-218D-4EDD-B8CE-D546364F2EDA

P698

Q27026350-39C3420C-7D36-44A8-A539-B9430A6027A0

P932

Q27026350-8519CB57-D6AB-4849-96C5-E714A6464EDF

P3181

P356

ALN.0000000000000446

P1433

P1476

Cell-based therapy for acute o ...... s using mesenchymal stem cells

@en

P2093

Jae W Lee

http://www.w3.org/2001/XMLSchema#string

Jia Liu

http://www.w3.org/2001/XMLSchema#string

Qi Hao

http://www.w3.org/2001/XMLSchema#string

Stephane Gennai

http://www.w3.org/2001/XMLSchema#string

Ying-Gang Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6

Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia

Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect

Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats

P304

1099-1121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1095036

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/ALN.0000000000000446

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25211170

http://www.w3.org/2001/XMLSchema#string

P932

4206665

http://www.w3.org/2001/XMLSchema#string